The core programming of Gavi, the Vaccine Alliance, has not been affected by the Trump administration’s recent cuts to the United States Agency for International Development (USAID), according to a statement from the organisation.
Gavi, which helps vaccinate more than half the world’s children against infectious diseases, received approximately $300 million from the U.S. government in December 2024. This follows a pledge made by the Biden administration last June to provide at least $1.58 billion to the organisation over a five-year period.
However, some uncertainty remains regarding future U.S. funding for the partnership. Gavi typically expects to receive additional funding from the U.S. in the third quarter of the year, but Congress has yet to finalise the federal budget for 2025, which will determine Gavi’s contribution.
“While we are very concerned by the cuts being made to global health, Gavi has always been able to draw on strong bipartisan support in the US,” a Gavi spokesperson told Devex. “Therefore, we remain hopeful – given the importance immunisation plays in keeping everyone safe from infectious disease – that we will be able to continue our partnership.”
The spokesperson added that it remains unclear what internal administrative processes will be involved in disbursing these congressional appropriations once they are finalised.
According to KFF, a health policy research organisation, the U.S. government has supported Gavi since its creation through direct financial contributions, participation in governance, and technical assistance. The U.S. is currently the third-largest contributor to Gavi and the second-largest government contributor, providing 12% of the organisation’s overall funding.
Gavi is currently in the midst of an investment campaign seeking to secure nine billion dollars from donors for its programming from 2026 to 2030. Since its creation in 2000, Gavi reports having vaccinated over one billion children and helped to cut child mortality in half across 78 lower-income countries. The organisation provides vaccines against 20 infectious diseases, including Ebola, malaria, and rabies.
Despite the overall stability of its core programming, Gavi did receive one contract termination notice from USAID related to COVID-19. The funds under this contract were disbursed in 2021 and had already been used for COVID-19-related immunization, prevention, and response activities.
Follow the AkweyaTV channel on WhatsApp: https://whatsapp.com/channel/0029Va7m7dvJuyA7h5XMc22i
